The Association of Healthcare Value Analysis Professionals (AHVAP), along with Baptist’s Value Analysis team, celebrated the 2025 Value Analysis Week from July 21 to July 25 to recognize and highlight the role played by health care value analysis professionals and leaders in improving patient care, costs and outcomes.
Baptist first formally introduced value analysis as a clinically integrated supply chain in 2016 by initiating best practices for optimal patient outcomes while meeting financial goals. Karli Caruso, system director, Value Analysis and Spend Management; Mary Harpole-Snider, manager, Value Analysis and Spending; and Torilan Dancy, manager, Supply Chain Analytics, have been instrumental in developing the Value Analysis team at Baptist and continue to provide dedicated leadership. Caruso and Harpole-Snider are both certified value analysis health care professionals with Executive Master of Science in Nursing degrees.
There are four registered nurses on the Value Analysis team — Caruso and Harpole-Snider on the leadership side, and Alana Carlise and Olivia Hollis, two knowledgeable registered nurses who make up the clinical support team.
Carlisle and Hollis have been influential in driving all new product requests and system standardization opportunities for Baptist. The team also includes three pricing analysts who are instrumental in behind-the-scenes analytical and pricing work.
The Value Analysis team implemented a governance model that actively engages physicians and leadership, leveraging up-to-date data insights to drive evidence-based decisions. The team also developed a comprehensive methodology to integrate clinical and supply data, allowing for timely monitoring and sustainable standardization.
“Through this initiative, Baptist has refined its ability to make data-driven decisions, optimize operational efficiency and foster a sustainable framework for physician engagement,” said Caruso. “The experience gained has strengthened our capacity to implement informed strategies that improve both patient care and financial performance and to identify performance gaps and measure the impact of market share adherence.”
To address ongoing supply variations, the team introduced user-friendly tools to empower frontline clinical leaders in driving change. The integration of clear, concise and timely visual analytics has further streamlined the evaluation of standardization efforts.
“By systematically evaluating medical devices based on clinical efficacy, safety and financial impact, Baptist continues to drive value-based care while maintaining cost-effectiveness and supply chain integrity,” said Caruso.
